REVIEW
|
doi:10.20944/preprints202207.0464.v1
Subject:
Medicine And Pharmacology,
Urology And Nephrology
Keywords:
prostate cancer; six-transmembrane epithelial antigen of the prostate; biomarker; immunotherapy; cancer vaccine; T-cell engaging antibody
Online: 29 July 2022 (14:02:03 CEST)